Cancer is a complex disease in which normal cells lose control, proliferate abnormally and invade surrounding tissues, and even spread to other parts of the body. This process is usually due to the accumulation of gene mutations, leading to abnormal regulation of cell growth mechanisms. There are various types of cancer, which can be divided into two categories according to the tissue origin: malignant solid tumors (such as lung cancer, breast cancer, colorectal cancer, etc.) and blood malignancies (such as leukemia, lymphoma, etc.). According to statistics, over 90% of cancer-related deaths are caused by cancer metastasis. With a deeper understanding of the tumor microenvironment, continuous research and development of anti-cancer drug targets, the flourishing development of genomics, and the rise of CAR-T cell therapy, the arrival of the era of precision immunotherapy for cancer has brought new hope to patients. In this challenging and hopeful scientific frontier, Immunoway is committed to providing high-quality and highly specific antibody tools to support global researchers in exploring the complex mechanisms of cancer and promoting the development of innovative cancer therapies.